Assessing the Efficacy of Dupilumab Use in Patients With Prurigo Nodularis and Investigating Treatment Efficacy–Related Indicators
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Baseline eosinophil level may be a predictive indicator for the effectiveness of Dupilumab in patients with prurigo nodularis: A single-center, real-world prospective study in China
J Am Acad Dermatol 2024 Jan 29;[EPub Ahead of Print], X Yi, Q Cao, C Peng, Q Jia, J LiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.